Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses

American Journal of Physiology

Volumn 273, Issue 3 PART 1, 1997, Pages

  Dewitt, Bracken J ^a   Champion, Hunter C ^b   Marrone, James R ^a   McNamara, Dennis B ^a   Giles, Thomas D ^b   Greenberg, Stanley S ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist induced release of nitric oxide; Basal release of nitric oxide; Inhibition of nitric oxide synthesis

Indexed keywords

EID: 33745413503     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gmethylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun. 160: 881-886, 1989.
2. Archer, S. L., J. P. Tolins, L. Rai, and E. K. Weir. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem. Biophys. Res. Commun. 164:1198-1205, 1989.
3. Bellan, J. A., T. J. McMahon, R. K. Minkes, and P. J. Kadowitz. Antagonists of a-adrenergic, vasopressin-1, and angiotensin II receptors attenuate the pressor response to AnitroL-arginine methyl ester (Abstract). Circulation 86:1-833, 1992.
4. Bellan, J. A., D. B. McNamara, and P. J. Kadowitz. Differential effects of nitric oxide synthesis inhibitors on vascular resistance and responses to acetylcholine in cats. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H45-H52, 1993.
5. Cheng, D. Y, B. J. DeWitt, T. J. McMahon, and P. J. Kadowitz. Comparative effects of L-NNA and alkyl esters of L-NNA on pulmonary vasodilator responses to ACh, BK, and SP. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2416-H2422, 1994.
6. ω-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation. Eur. J. Pharmacol. 263:133-140, 1994.
7. Furchgott, R. F., and J. V. Zawadski. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
8. G-nitro-Larginine methyl ester in conscious, Long Evans rats. Br. J. Pharmacol. 101: 625-631, 1990.
9. Gold, M. E., K. S. Wood, G. M. Buga, R. E. Byrns, and L. J. Ignarro. L-Arginine causes whereas L-arginine succinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. Biochem. Biophys. Res. Commun. 161: 536-543, 1989.
10. Greenberg, S. S., J. Xie, J. M. Zatarain, D. R. Kapusta, and M. J. S. Miller. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J. Pharmacol. Exp. Ther. 273: 257-265, 1995.
11. Greenberg, S. S., J. Xie, X. Zhao, O. Jie, and T. D. Giles. An in vivo cytokine and endotoxin-independent pathway for induction of nitric oxide synthase II mRNA, enzyme, and nitrate/ nitrite in alveolar macrophages. Biochem. Biophys. Res. Commun. 227:160-167, 1996.
12. Hampl, V., S. L. Archer, D. P. Nelson, and E. K. Weir. Chronic EDRF inhibition and hypoxia effects on pulmonary circulation and systemic blood pressure. J. Appl. Physiol. 75: 1748-1757, 1993.
13. Hoeffner, U., M. Feletou, N. A. Flavahan, and P. M. Vanhoutte. Canine arteries release two different endothelium-derived relaxing factors. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H330-H333, 1989.
14. Ignarro, L. J., R. E. Byrns, G. E. Buga, and K. S. Wood. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologie and chemical properties identical to those of nitric oxide radical. Circ. Res. 61: 866-879, 1987.
15. Kerwin, J. F., Jr., J. R. Lancaster, Jr., and P. L. Feldman. Nitric oxide: a new paradigm for second messengers. J. Med. Chem. 38: 4343-4362, 1995.
16. Knowles, R. G., M. Palacios, R. M. J. Palmer, and S. Moncada. Kinetic characteristics of nitric oxide synthase from rat brain. Biochem. J. 269: 207-210, 1990.
17. McCall, T. B., M. Feelisch, R. M. J. Palmer, and S. Moncada. Identification of JV-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. 102:234-238, 1991.
18. McMahon, T. J., J. S. Hood, J. A. Bellan, and P. J. Kadowitz. Anitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J. Appl. Physiol. 71: 2026-2031, 1991.
19. ω-nitroL-arginine methyl ester in the cat. Circ. Res. 70: 364-369, 1992.
20. Mügg, A., J. A. G. Lopez, D. J. Piegors, K. R. Breese, and D. D. Heistad. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H242-H247, 1991.
21. Mulligan, M. S., S. Moncada, and P. A. Ward. Protective effects of inhibitors of nitric oxide synthase in immune complexinduced vasculitis. Br. J. Pharmacol. 107: 1159-1162, 1992.
22. Palacios, M., R. G. Knowles, R. M. J. Palmer, and S. Moncada. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem. Biophys. Res. Commun. 165: 802-809, 1989.
23. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 327: 524-526, 1987.
24. Palmer, R. M. J., and S. Moncada. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158: 348352, 1989.
25. Persson, M. G., T. Midtredt, A. M. Leone, and L. E. Gustafsson. Ca2+-dependent and Ca2+-independent exhaled nitric oxide, presence in germ-free animals, and inhibition by arginine analogues. Eur. J. Pharmacol. 264:13-20, 1994.
26. Rees, D. D., R. M. J. Palmer, and S. Moncada. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 86: 3375-3378, 1989.
27. Rees, D. D., R. M. J. Palmer, R. Schulz, H. F. Hodson, and S. Moncada. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746-752, 1990.
28. Ross, G., G. Chaudhuri, L. J. Ignarro, and K.-Y. Chyu. Acetylcholine vasodilation of resistance vessels in vivo may not entirely depend on newly synthesized nitric oxide. Eur. J. Pharmacol. 195: 291-293, 1991.
29. 5-d-iminoethyl) ornithine. J. Antibiot. 25: 179-184, 1972.
30. Smith, R. E. A., R. M. J. Palmer, C. A. Bucknall, and S. Moncada. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc. Res. 26: 508-512, 1992.
31. Xie, J., J. Rolls, G. Bagby, and S. S. Greenberg. Independent suppression of nitric oxide and TNFa in the lung of conscious rats by ethanol. FASEB J. 9: 253-261, 1995.